GUARDANT HEALTH, INC. Operating Income
GUARDANT HEALTH, INC. (GH) reported Operating Income of -$129.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-30
- GUARDANT HEALTH, INC. operating income (loss) for the quarter ending 2026-06-30 was -$129.12M.
- GUARDANT HEALTH, INC. operating income (loss) for the quarter ending 2026-03-31 was -$121.35M.
- GUARDANT HEALTH, INC. operating income (loss) for the quarter ending 2025-12-31 was -$120.81M.
- GUARDANT HEALTH, INC. operating income (loss) for the quarter ending 2025-09-30 was -$98.99M.
- GUARDANT HEALTH, INC. operating income (loss) for fiscal 2025 was -$437.25M.
- GUARDANT HEALTH, INC. operating income (loss) for fiscal 2024 was -$443.59M.
- GUARDANT HEALTH, INC. operating income (loss) for fiscal 2023 was -$564.73M.
- GUARDANT HEALTH, INC. operating income (loss) for fiscal 2022 was -$544.38M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$129.12M 10-Q · filed 2026-07-30 | -$250.47M 10-Q · filed 2026-07-30 | -$371.27M derived: sum of 3 quarters · filed 2026-07-30 | -$470.26M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$121.35M 10-Q · filed 2026-05-07 | -$242.16M derived: sum of 2 quarters · filed 2026-05-07 | -$341.14M derived: sum of 3 quarters · filed 2026-05-07 | -$447.56M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$120.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$219.79M derived: sum of 2 quarters · filed 2026-02-19 | -$326.21M derived: sum of 3 quarters · filed 2026-07-30 | -$437.25M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$98.99M 10-Q · filed 2025-10-29 | -$205.40M derived: sum of 2 quarters · filed 2026-07-30 | -$316.44M 10-Q · filed 2025-10-29 | -$442.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$106.41M 10-Q · filed 2026-07-30 | -$217.45M 10-Q · filed 2026-07-30 | -$343.42M derived: sum of 3 quarters · filed 2026-07-30 | -$460.75M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$111.04M 10-Q · filed 2026-05-07 | -$237.01M derived: sum of 2 quarters · filed 2026-05-07 | -$354.33M derived: sum of 3 quarters · filed 2026-05-07 | -$454.95M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$125.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$243.29M derived: sum of 2 quarters · filed 2026-02-19 | -$343.91M derived: sum of 3 quarters · filed 2026-02-19 | -$443.59M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$117.33M 10-Q · filed 2025-10-29 | -$217.95M derived: sum of 2 quarters · filed 2025-10-29 | -$317.63M 10-Q · filed 2025-10-29 | -$515.14M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$100.62M 10-Q · filed 2025-07-30 | -$200.30M 10-Q · filed 2025-07-30 | -$397.81M derived: sum of 3 quarters · filed 2026-02-19 | -$511.36M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$99.68M 10-Q · filed 2025-04-30 | -$297.19M derived: sum of 2 quarters · filed 2026-02-19 | -$410.74M derived: sum of 3 quarters · filed 2026-02-19 | -$530.35M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$197.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$311.05M derived: sum of 2 quarters · filed 2026-02-19 | -$430.67M derived: sum of 3 quarters · filed 2026-02-19 | -$564.73M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$113.54M 10-Q · filed 2024-11-06 | -$233.16M derived: sum of 2 quarters · filed 2024-11-06 | -$367.21M 10-Q · filed 2024-11-06 | -$513.33M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$119.62M 10-Q · filed 2024-08-07 | -$253.67M 10-Q · filed 2024-08-07 | -$399.79M derived: sum of 3 quarters · filed 2025-02-20 | -$544.39M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | -$134.06M 10-Q · filed 2024-05-09 | -$280.17M derived: sum of 2 quarters · filed 2025-02-20 | -$424.77M derived: sum of 3 quarters · filed 2025-02-20 | -$555.10M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | -$146.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$290.72M derived: sum of 2 quarters · filed 2025-02-20 | -$421.04M derived: sum of 3 quarters · filed 2025-02-20 | -$544.38M 10-K · filed 2025-02-20 |
| 2022-09-30 | -$144.60M 10-Q · filed 2023-11-06 | -$274.92M derived: sum of 2 quarters · filed 2023-11-06 | -$398.26M 10-Q · filed 2023-11-06 | -$496.47M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$130.32M 10-Q · filed 2023-08-03 | -$253.66M 10-Q · filed 2023-08-03 | -$351.87M derived: sum of 3 quarters · filed 2024-02-22 | -$459.15M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$123.34M 10-Q · filed 2023-05-09 | -$221.55M derived: sum of 2 quarters · filed 2024-02-22 | -$328.83M derived: sum of 3 quarters · filed 2024-02-22 | -$426.48M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$98.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$205.50M derived: sum of 2 quarters · filed 2024-02-22 | -$303.14M derived: sum of 3 quarters · filed 2024-02-22 | -$411.00M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$107.29M 10-Q · filed 2022-11-03 | -$204.93M derived: sum of 2 quarters · filed 2022-11-03 | -$312.79M 10-Q · filed 2022-11-03 | -$403.96M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$97.64M 10-Q · filed 2022-08-04 | -$205.50M 10-Q · filed 2022-08-04 | -$296.67M derived: sum of 3 quarters · filed 2023-02-23 | -$370.92M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$107.86M 10-Q · filed 2022-05-05 | -$199.03M derived: sum of 2 quarters · filed 2023-02-23 | -$273.28M derived: sum of 3 quarters · filed 2023-02-23 | -$327.90M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$91.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$165.42M derived: sum of 2 quarters · filed 2023-02-23 | -$220.04M derived: sum of 3 quarters · filed 2023-02-23 | -$254.95M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$74.25M 10-Q · filed 2021-11-04 | -$128.87M derived: sum of 2 quarters · filed 2021-11-04 | -$163.78M 10-Q · filed 2021-11-04 | -$189.75M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$54.62M 10-Q · filed 2021-08-05 | -$89.53M 10-Q · filed 2021-08-05 | -$115.49M derived: sum of 3 quarters · filed 2022-02-24 | -$132.97M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$34.91M 10-Q · filed 2021-05-06 | -$60.87M derived: sum of 2 quarters · filed 2022-02-24 | -$78.35M derived: sum of 3 quarters · filed 2022-02-24 | -$93.62M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$25.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$43.44M derived: sum of 2 quarters · filed 2022-02-24 | -$58.71M derived: sum of 3 quarters · filed 2022-02-24 | -$82.37M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$17.48M 10-Q · filed 2020-11-05 | -$32.74M derived: sum of 2 quarters · filed 2020-11-05 | -$56.41M 10-Q · filed 2020-11-05 | -$83.80M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$15.27M 10-Q · filed 2020-08-06 | -$38.93M 10-Q · filed 2020-08-06 | -$66.32M derived: sum of 3 quarters · filed 2021-02-25 | -$90.52M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$23.66M 10-Q · filed 2020-05-07 | -$51.05M derived: sum of 2 quarters · filed 2021-02-25 | -$75.26M derived: sum of 3 quarters · filed 2021-02-25 | -$97.96M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$27.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$51.59M derived: sum of 2 quarters · filed 2021-02-25 | -$74.30M derived: sum of 3 quarters · filed 2021-02-25 | -$92.94M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$24.20M 10-Q · filed 2019-11-07 | -$46.91M derived: sum of 2 quarters · filed 2019-11-07 | -$65.56M 10-Q · filed 2019-11-07 | -$81.17M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$22.70M 10-Q · filed 2019-08-07 | -$41.35M 10-Q · filed 2019-08-07 | -$56.97M derived: sum of 3 quarters · filed 2020-03-02 | -$85.64M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$18.65M 10-Q · filed 2019-05-10 | -$34.26M derived: sum of 2 quarters · filed 2020-03-02 | -$62.94M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2017-12-31 | -$15.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$44.30M derived: sum of 2 quarters · filed 2020-03-02 | -$76.61M 10-K · filed 2020-03-02 | |
| 2017-09-30 | -$28.68M 10-Q · filed 2018-11-19 | -$60.99M 10-Q · filed 2018-11-19 | ||
| 2016-12-31 | -$43.85M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |